Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
TARS
#1395
Tarsus Pharmaceuticals, Inc. Common Stock
75.520
0
+1.46%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.46%
Changement Mensuel
+11.06%
Evolution sur 6 mois
+14.32%
Changement Annuel
+14.32%
Clôture Précédente
74.435
0
Open
75.520
0
Bid
Ask
Low
75.520
0
High
75.520
0
Volume
74
Marchés
Actions des Marchés US
Soins de Santé
TARS
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
20.5 M
20.71 M
26.73 M
34.22 M
38.38 M
42.56 M
—
Valuation ratios
Enterprise value
679.29 M
294.65 M
313.81 M
464.91 M
2.03 B
3.3 B
9.31 B
Price to earnings ratio
—
-33.58
-5.72
-4.36
-18.04
-51.5
-118
Price to sales ratio
—
8.11
13.75
33.95
11.38
7.58
28.09
Price to cash flow ratio
—
123.39
7.24
5.04
25.08
274.78
367.61
Price to book ratio
—
2.77
1.84
3.01
9.27
9.96
15.19
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.08
0.27
0.51
0.31
0.12
0.13
Return on equity %
0.16
0.08
0.32
0.69
0.51
0.19
0.2
Return on invested capital %
1 906.57
561.75
2 112.36
2 838.11
1 840.82
579.31
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
21.32
242.92
820.53
65.9
15.72
72.66
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
24.25
240.51
778.89
63.16
14.72
68
Liquidity ratios
Quick ratio
—
—
—
6.85
4.39
3.82
18.83
Current ratio
31.68
15.33
14.61
6.93
4.42
3.85
18.97
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.33
0.13
0.07
0.57
0.96
0.89
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.09
0.11
0.19
0.13
0.55
Long term debt to total equity ratio
—
—
0.1
0.15
0.32
0.21
0.85
Per share metrics
Operating cash flow per share
—
0.18
1.99
4
2.21
0.3
0.33
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
8.36
8.82
7.74
7.75
9.99
38.78
Net current asset value per share
—
8.56
9.15
8.72
9.49
12.51
47.71
Tangible book value per share
—
8.11
7.84
6.57
5.75
8.04
31.89
Working capital per share
—
8
8.53
7.46
7.34
9.26
37.39
Book value per share
—
8.11
7.84
6.7
5.97
8.22
32.64
Nouvelles
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens
Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders
AMD, IBM among market cap stock movers on Tuesday
Le BPA de Tarsus a manqué les attentes de 0,12$, le CA a surpassé les prévisions
Tarsus earnings missed by $0.12, revenue topped estimates
Tarsus Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-02-23
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth
Tarsus face à un test de résultats alors que les pertes se réduisent et le chiffre d’affaires bondit
Tarsus faces earnings test as losses narrow, revenue surges
Mirum Pharmaceuticals, Inc. (MIRM) Earnings Expected to Grow: What to Know Ahead of Q4 Release